Loading Complete
Mario P. Caturegli

Mario P. Caturegli, MD, MPH

Pathology

Highlights

Languages

  • Spanish
  • Italian
  • English

Gender

Male

Johns Hopkins Affiliations:

  • Johns Hopkins School of Medicine Faculty

About Mario P. Caturegli

Professional Titles

  • Director, Hypophysitis Center

Primary Academic Title

Professor of Pathology

Background

Dr. Patrizio P. Caturegli is a professor of pathology at the Johns Hopkins University School of Medicine. An immunopathologist, Dr. Caturegli is the director of the Johns Hopkins Hypophysitis Center and serves on the faculty of the Autoimmune Disease Research Center.

His clinical and research focus is autoimmune diseases of the endocrine glands. These include myocarditis, thyroiditis, hypophysitis, Sjogren's syndrome, and complete congenital heart blockage.

Dr. Caturegli earned his medical degree from Italy’s Faculty of Medicine E Chirurgua University of Pisa. He completed a residency in endocrinology at the University of Pisa and a residency in pathology at Johns Hopkins. He performed a fellowship in public health at Johns Hopkins where he also earned a M.P.H. from Hopkins’ Bloomberg School of Public Health. He joined the Johns Hopkins faculty in 1999.

He has published more than 100 journal articles.

Centers and Institutes

Autoimmune Disease Research Center

Additional Academic Titles

Professor of Medicine

Research Interests

Autoantibodies, Autoimmune disease, Congenital complete heart block, Endocrinology, Hurthle cell lesions, Hypophysitis, Myocarditis, Pituitary disease, Sjogren's syndrome, Thyroglobulin, Thyroid disease, Thyroid peroxidase (TPO), Thyroiditis

Research Summary

Dr. Caturegli’s research focuses on autoimmune diseases of the endocrine glands, with particular focus on those affecting the thyroid and pituitary.

His team has shown that transgenic mice expressing interferon-gamma specifically in the thyroid gland develop a metaplastic transformation of the thyrocyte resembling the human Hürthle cell, a cell characteristically found in Hashimoto thyroiditis.

This transformation depends upon the overexpression of the immunoproteasome—specifically, its LMP2 subunit.

Our team is now evaluating the efficacy of new immunoproteasome inhibitors for the treatment of Hürthle cell lesions.

In the pituitary model, studies have led to the development of a mouse model of autoimmune hypophysitis, a model the lab is using to explore two aspects relevant to human health: 

  • The identification of the pituitary antigens recognized by the immune system in patients with hypophysitis 
  • The recently reported association between hypophysitis and treatments used in patients with cancer to block T cell inhibitory signals, such as CTLA-4

Selected Publications

  • Caturegli P, De Remigis A, Chuang K, Dembele M, Iwama A, Iwama S. Hashimoto's thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records. Thyroid. 2013 Feb;23(2):142-50

  • Caturegli P, De Remigis A, Ferlito M, Landek-Salgado MA, Iwama S, Tzou SC, Ladenson PW. Anatabine ameliorates experimental autoimmune thyroiditis. Endocrinology. 2012 Sep;153(9):4580-7

  • Caturegli P, De Remigis A, Rose NR. “Hashimoto thyroiditis: clinical and diagnostic criteria.” Autoimmun Rev. 2014 Apr-May;13(4-5):391-7. doi: 10.1016/j.autrev.2014.01.007. Epub 2014 Jan 13. Review

  • Bose V, Caturegli P, Conrad J, Omran W, Boor S, Giese A, Gutenberg A. Use of a clinicoradiological score to determine the presurgical diagnosis of autoimmune hypophysitis in a teenage girl. J Neurosurg Pediatr. 2013 Mar;11(3):335-9

  • De Remigis A, de Gruijl TD, Uram JN, Tzou SC, Iwama S, Talor MV, Armstrong TD, Santegoets SJ, Slovin SF, Zheng L, Laheru DA, Jaffee EM, Gerritsen WR, van den Eertwegh AJ, Le DT, Caturegli P. “Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival.” Int J Cancer. 2014 May 15. doi: 10.1002/ijc.28973. [Epub ahead of print]

  • Iwama S, De Remigis A, Bishop JA, Kimura HJ, Caturegli P. Hürthle cells predict hypothyroidism in interferon-? transgenic mice of different genetic backgrounds.Endocrinology. 2012 Aug;153(8):4059-66
     

  • Iwama S, De Remigis A, Callahan MK, Slovin SF, Wolchok JD, Caturegli P. “Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody.” Sci Transl Med. 2014 Apr 2;6(230):230ra45. doi: 10.1126/scitranslmed.3008002

  • Lupi I, Raffaelli V, Di Cianni G, Caturegli P, Manetti L, Ciccarone AM, Bogazzi F, Mariotti S, Del Prato S, Martino E. Pituitary autoimmunity in patients with diabetes mellitus and other endocrine disorders. J Endocrinol Invest. 2013 Feb;36(2):127-31

  • Maleszewski JJ, Murray DL, Dispenzieri A, Grogan M, Pereira NL, Jenkins SM, Judge DP, Caturegli P, Vrana JA, Theis JD, Dogan A, Halushka MK. Relationship between monoclonal gammopathy and cardiac amyloid type. Cardiovasc Pathol. 2012 Oct 24

  • McLeod DS, Caturegli P, Cooper DS, Matos PG, Hutfless S. “Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel.” JAMA. 2014 Apr 16;311(15):1563-5. doi: 10.1001/jama.2013.285606. No abstract available.

  • Ricciuti A, De Remigis A, Landek-Salgado MA, De Vincentiis L, Guaraldi F, Lupi I, Iwama S, Wand GS, Salvatori R, Caturegli P. “Detection of pituitary antibodies by immunofluorescence: approach and results in patients with pituitary diseases.” J Clin Endocrinol Metab. 2014 May;99(5):1758-66. doi: 10.1210/jc.2014-1049. Epub 2014 Feb 25

Courses & Syllabi

Autoimmune Diseases of the Endocrine Glands, 260.633.01

Graduate Program Affiliations

  • Cellular and Molecular Medicine

    Pathobiology

    Molecular Microbiology and Immunology

    Pathobiology

Locations

  1. The Johns Hopkins Hospital
    • 1800 Orleans Street, Baltimore, MD 21287

    Expertise

    Education

    Johns Hopkins Bloomberg School of Public Health

    Graduate School, MPH, 2004

    Johns Hopkins University School of Medicine

    Residency, Pathology, 1998

    Pisa University Hospital

    Residency, Endocrinology, 1993

    University of Pisa Faculty of Medicine & Health Sciences

    Medical Education, MD, 1987

    Board Certifications

    Clinical Pathology

    American Board of Pathology, 1999

    Insurance

    Johns Hopkins providers accept various commercial health insurance plans. However, they may not be included in all of an insurance company's plans or offerings. This may include Exchange, Medicaid, Medicare, and specific limited benefit plans. Exceptions to participation also exist based on your employer’s benefits package and the provider's location or specialty. Please contact your insurer directly to make sure your doctor is covered by your plan. For more details, please review our Insurance Information.
    Search plans
    • Aetna
    • CareFirst
    • Cigna
    • First Health
    • Geisinger Health Plan
    • HealthSmart/Accel
    • Humana
    • Johns Hopkins Health Plans
    • MultiPlan
    • Pennsylvania's Preferred Health Networks (PPHN)
    • Point Comfort Underwriters
    • Private Healthcare Systems (PHCS)
    • UnitedHealthcare
    • Veteran Affairs Community Care Network (Optum-VACCN)